Table 3.
Characterization of silica nanoparticles
| Investigators | Nanoparticles (NPs) |
Average particle size (nm)(±S.D.) | Zeta potential (mV)(±S.D.) |
Entrapment efficiency (EE%) | Drug loading (DL%) |
Drug release % |
PDI |
|---|---|---|---|---|---|---|---|
| Zhao et al. 37 | SO@MSN-CS-LA | 210.9 (±2.8) | +7.7 (±2.6) | 57.4(±2.1) | 21.3(±0.9) | 24.9(pH=7.4) 65.0(pH=5.5) |
0.258 (±0.022) |
| Ye et al. 131 | LDL-SLN/Sor/Dox | 110.9(±6.8) | -18.3(±4.1) | -- | 37.1 | <15(pH=7.4) 47.6(pH=5.5) |
0.118 |
| Zheng et al. 138 | SO/siVEGF@MSN-LA | 148.5 (±3.5) | + 8.3(±3.5) | 55.3(±2.9) | 21.8(±1.6) | ≈30(pH=7.4) ≈60(pH=5.5) |
0.153(±0.072) |
| Tang et al. 195 | MMSNs@SO 5(TEOS): 1(MnCl2) |
102.6(±3.06) | -25.43 | 5.36(±0.64) | 2.68(±0.32) | 5.02±1.05(pH=7.4) 23.13±1.45(pH=5.0) |
0.119(±0.01) |
| Yang et al. 174 | (ICG+S)@mSiO2 ICG(1):S(3) |
≈100 | ≈-17 | -- | 9.75 | 18.8(pH=7.4) 22.36(pH=5.5) |
-- |